Compare LAZ & EXPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAZ | EXPO |
|---|---|---|
| Founded | 1848 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Professional Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 3.6B |
| IPO Year | 2005 | 1990 |
| Metric | LAZ | EXPO |
|---|---|---|
| Price | $49.59 | $70.05 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $55.38 | ★ $81.00 |
| AVG Volume (30 Days) | ★ 940.6K | 435.7K |
| Earning Date | 01-29-2026 | 02-05-2026 |
| Dividend Yield | ★ 4.02% | 1.71% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.52 | 2.03 |
| Revenue | ★ $3,016,853,000.00 | $531,142,000.00 |
| Revenue This Year | $0.62 | $5.35 |
| Revenue Next Year | $17.34 | $7.90 |
| P/E Ratio | ★ $19.76 | $34.56 |
| Revenue Growth | N/A | ★ 4.43 |
| 52 Week Low | $31.97 | $63.81 |
| 52 Week High | $58.07 | $97.57 |
| Indicator | LAZ | EXPO |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 41.64 |
| Support Level | $48.83 | $71.99 |
| Resistance Level | $50.29 | $75.01 |
| Average True Range (ATR) | 1.25 | 1.65 |
| MACD | -0.17 | -0.48 |
| Stochastic Oscillator | 35.54 | 20.40 |
Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.